Neurobiologist Karl Herrup shares his take on why the field of Alzheimer’s has struggled to find a cure, and what it would take to…
Clinical trials are recruiting younger, healthier participants for Alzheimer’s studies like the new TRAILBLAZER 3 donanemab clinical trial. Alzheimer’s is a notoriously difficult disease…
What’s the difference between treating Alzheimer’s symptoms and modifying the disease? Most FDA-approved Alzheimer’s drugs are designed just to address symptoms. Now, a new…
While recent work suggests personality traits may be associated with hallmarks of Alzheimer’s pathology, it does not show cause-and-effect or associate these hallmarks with…
Following the approval of the Alzheimer’s drug Aduhelm — and the litany of controversy surrounding it — one question that’s top of mind for…
Can Roche’s investigational anti-amyloid drug, gantenerumab, help slow down or even prevent Alzheimer’s disease? Trials are underway. The amyloid hypothesis—the idea that Alzheimer’s is…
A recent study of mice and humans indicates that breathing pure oxygen in highly pressurized chambers may improve cognitive impairment and reduce Alzheimer’s pathology….